Serological response and breakthrough infection after COVID-19 vaccination in patients with cirrhosis and postliver transplant.

MLA

Mehta, Gautam, et al. “Serological Response and Breakthrough Infection after COVID-19 Vaccination in Patients with Cirrhosis and Postliver Transplant.” Hepatology Communications, vol. 7, no. 11, Nov. 2023, pp. 1–25. EBSCOhost, https://doi.org/10.1097/HC9.0000000000000273.

APA

Mehta, G., Riva, A., Ballester, M. P., Uson, E., Pujadas, M., Carvalho-Gomes, Â., Sahuco, I., Bono, A., D’Amico, F., Viganò, R., Diago, E., Lanseros, B. T., Inglese, E., Vazquez, D. M., Sharma, R., Hio Lam Phoebe Tsou, Harris, N., Broekhoven, A., Kikkert, M., & Torres Morales, S. P. (2023). Serological response and breakthrough infection after COVID-19 vaccination in patients with cirrhosis and postliver transplant. Hepatology Communications, 7(11), 1–25. https://doi.org/10.1097/HC9.0000000000000273

Chicago

Mehta, Gautam, Antonio Riva, Maria Pilar Ballester, Eva Uson, Montserrat Pujadas, Ângela Carvalho-Gomes, Ivan Sahuco, et al. 2023. “Serological Response and Breakthrough Infection after COVID-19 Vaccination in Patients with Cirrhosis and Postliver Transplant.” Hepatology Communications 7 (11): 1–25. doi:10.1097/HC9.0000000000000273.